UPDATED Jun 27, 2024
Companies with strong growth potential, backed by optimistic outlooks both from analysts and management.
Company | Last Price | 7D Return | 1Y Return | Market Cap | Analysts Target | Valuation | Growth | Div Yield | Industry | ||
---|---|---|---|---|---|---|---|---|---|---|---|
KEBNI B | SEK 1.62 | -2.9% | 30.6% | SEK 439.8m | SEK 2.20 | PS4.8x | E90.4% | n/a | Tech | ||
CALTX | SEK 205.60 | 0.4% | 140.0% | SEK 11.0b | SEK 221.25 | PS8.4x | E52.9% | n/a | Pharmaceuticals & Biotech | ||
YUBICO | SEK 235.50 | 1.7% | 140.3% | SEK 20.3b | SEK 265.00 | PE122.5x | E43.8% | n/a | Software | ||
CTT | SEK 328.00 | -6.0% | 57.7% | SEK 4.1b | n/a | PE40.3x | E21.6% | 1.6% | Capital Goods | ||
SILEON | SEK 0.63 | 4.2% | -85.3% | SEK 31.7m | n/a | PB2x | E109.3% | n/a | Software | ||
YIELD | SEK 2.45 | 0% | -67.1% | SEK 131.2m | SEK 9.00 | PB1.5x | E103.4% | n/a | Diversified Financials | ||
BIOA B | SEK 221.00 | 2.3% | -20.4% | SEK 19.5b | SEK 368.00 | PS77.4x | E50.9% | 0% | Pharmaceuticals & Biotech | ||
EDYOU | SEK 0.49 | 3.6% | -38.7% | SEK 18.5m | n/a | PB0.3x | E63.1% | n/a | Media | ||
BIOVIC B | SEK 2.70 | 3.7% | -58.0% | SEK 226.5m | SEK 7.90 | PS31.1x | E73.8% | n/a | Pharmaceuticals & Biotech | ||
INCOAX | SEK 2.64 | -1.9% | -26.5% | SEK 285.5m | SEK 3.65 | PS3x | E104.9% | n/a | Tech | ||
CRAD B | SEK 42.30 | 1.6% | 50.3% | SEK 1.4b | SEK 56.00 | PE29.5x | E30.4% | n/a | Healthcare | ||
ORGC | SEK 3.95 | 4.2% | -11.6% | SEK 387.6m | SEK 3.00 | PS2.8x | E103.3% | n/a | Materials | ||
ORT B | SEK 8.46 | 3.2% | 14.3% | SEK 313.7m | SEK 18.00 | PS4.9x | E62.8% | n/a | Healthcare | ||
SENZA | SEK 7.15 | 2.9% | -36.4% | SEK 211.0m | SEK 17.25 | PS4.1x | E67.8% | n/a | Pharmaceuticals & Biotech | ||
MIDS | SEK 1.89 | 3.5% | -28.4% | SEK 397.2m | SEK 2.80 | PS6.2x | E89.9% | n/a | Semiconductors | ||
KLAR | SEK 0.43 | 7.8% | -15.7% | SEK 55.8m | SEK 1.00 | PB1.9x | E61.3% | n/a | Pharmaceuticals & Biotech | ||
EGTX | SEK 4.99 | -20.5% | 12.0% | SEK 1.5b | SEK 13.30 | PS23.2x | E99.0% | n/a | Pharmaceuticals & Biotech | ||
QLIRO | SEK 23.70 | 10.0% | 2.6% | SEK 452.0m | SEK 21.00 | PE70.6x | E71.9% | n/a | Diversified Financials | ||
NIUTEC | SEK 6.00 | -4.8% | -47.9% | SEK 119.2m | SEK 9.50 | PB1.4x | E94.1% | n/a | Capital Goods | ||
FNOX | SEK 63.48 | 2.7% | -3.0% | SEK 38.7b | SEK 73.78 | PE63.2x | E21.1% | 0.3% | Software | ||
ALELIO | SEK 0.05 | 0.6% | -91.2% | SEK 31.1m | n/a | PE-0.5x | E106.6% | n/a | Capital Goods | ||
ASAI | SEK 0.55 | -7.6% | -52.4% | SEK 205.2m | n/a | PS2.4x | E66.6% | n/a | Software | ||
NAVIGO STAM | SEK 4.10 | -7.2% | n/a | SEK 519.3m | n/a | PE663.1x | E77.4% | n/a | Diversified Financials | ||
FRAG | SEK 0.12 | -50.8% | -94.1% | SEK 13.3m | SEK 3.50 | PB0.06x | E122.8% | n/a | Media |